Impact of eNOS-Dependent Oxidative Stress on Endothelial Function and Neointima Formation

Antioxidants and Redox Signaling

Volumn 23, Issue 9, 2015, Pages 711-723

  Suvorava, Tatsiana ^a   Nagy, Nadine ^a   Pick, Stephanie ^a   Lieven, Oliver ^a   Rüther, Ulrich ^a   Dao, Vu Thao Vi ^a   Fischer, Jens W ^a   Weber, Martina ^b   Kojda, Georg ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALANINE; CITRULLINE; CYSTEINE; DIMER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MONOMER; NITRIC OXIDE; PEROXYNITRITE; SUPEROXIDE; NOS3 PROTEIN, HUMAN; NOS3 PROTEIN, MOUSE;

ANIMAL TISSUE; AORTA; AORTA ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HEART MUSCLE; HYPERPLASIA; MOLECULAR CLONING; MOUSE; NEOINTIMA; NEOINTIMAL HYPERPLASIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR REMODELING; VASODILATATION; ANIMAL; BOVINE; C57BL MOUSE; CARDIAC MUSCLE; GENETICS; HEK293 CELL LINE; HUMAN; KNOCKOUT MOUSE; METABOLISM; VASCULAR ENDOTHELIUM;

ALANINE; ANIMALS; AORTA; CATTLE; CITRULLINE; CYSTEINE; ENDOTHELIUM, VASCULAR; HEK293 CELLS; HUMANS; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; NEOINTIMA; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; SUPEROXIDES; VASODILATION;

EID: 84942046319     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6059     Document Type: Article

References (62)

1. This reference has been deleted.
2. Anea CB, Cheng B, Sharma S, Kumar S, Caldwell RW, Yao L, Ali MI, Merloiu AM, Stepp DW, Black SM, Fulton DJ, and Rudic RD. Increased superoxide and endothelial NO synthase uncoupling in blood vessels of Bmal1-knockout mice. Circ Res 111: 1157-1165, 2012.
3. Boger RH. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 38: 126-136, 2006.
4. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, and Rasmussen K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354: 1578-1588, 2006.
5. Chen PF, Tsai AL, and Wu KK. Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity. Biochem Biophys Res Commun 215: 1119-1129, 1995.
6. Cunnington C, Van Assche T, Shirodaria C, Kylintireas I, Lindsay AC, Lee JM, Antoniades C, Margaritis M, Lee R, Cerrato R, Crabtree MJ, Francis JM, Sayeed R, Ratnatunga C, Pillai R, Choudhury RP, Neubauer S, and Channon KM. Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation 125: 1356-1366, 2012.
7. Didion SP, Kinzenbaw DA, Schrader LI, Chu Y, and Faraci FM. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension 54: 619-624, 2009.
8. Dikalov S and Fink B. ESR techniques for the detection of nitric oxide in vivo and in tissues. Methods Enzymol 396: 597-610, 2005.
9. Erwin PA, Lin AJ, Golan DE, and Michel T. Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 280: 19888-19894, 2005.
10. Forstermann U and Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J 33: 829-837d, 2012.
11. Furchgott RF and Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
12. Gewaltig MT and Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 55: 250-260, 2002.
13. Gielis JF, Lin JY, Wingler K, Van Schil PE, Schmidt HH, and Moens AL. Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders. Free Radic Biol Med 50: 765-776, 2011.
14. Gorren AC and Mayer B. Nitric-oxide synthase: a cytochrome P450 family foster child. Biochim Biophys Acta 1770: 432-445, 2007.
15. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, and Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 26: 854-857, 1995.
16. Harmon KJ, Couper LL, and Lindner V. Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol 156: 1741-1748, 2000.
17. Harrison DG, Chen W, Dikalov S, and Li L. Regulation of endothelial cell tetrahydrobiopterin pathophysiological and therapeutic implications. Adv Pharmacol 60: 107-132, 2010.
18. Harrison DG and Gongora MC. Oxidative stress and hypertension. Med Clin North Am 93: 621-635, 2009.
19. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 23-33, 2002.
20. Heinzel B, John M, Klatt P, Böhme E, and Mayer B. Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 281: 627-630, 1992.
21. Hui DY. Intimal hyperplasia in murine models. Curr Drug Targets 9: 251-260, 2008.
22. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, and Brandes RP. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109: 1795-1801, 2004.
23. Kang DH and Kang SW. Targeting cellular antioxidant enzymes for treating atherosclerotic vascular disease. Biomol Ther (Seoul) 21: 89-96, 2013.
24. Kojda G, Hacker A, and Noack E. Effects of non-intermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and vascular superoxide production. Eur J Pharmacol 355: 23-31, 1998.
25. Kojda G and Hambrecht R. Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 67: 187-197, 2005.
26. Kojda G, Laursen JB, Ramasamy S, Kent JD, Kurz S, Burchfield J, Shesely EG, and Harrison DG. Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control. Cardiovasc Res 42: 206-213, 1999.
27. Kumar A and Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 17: 2238-2244, 1997.
28. Kuzkaya N, Weissmann N, Harrison DG, and Dikalov S. Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol 70: 343-354, 2005.
29. Langille BL and O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231: 405-407, 1986.
30. Lassegue B, San MA, and Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 110: 1364-1390, 2012.
31. Lauer N, Suvorava T, Rüther U, Jacob R, Meyer A, Harrison DG, and Kojda G. Critical involvement of hydrogen peroxide in exercise-induced upregulation of endothelial NO-synthase. Cardiovasc Res 65: 254-262, 2005.
32. Laufs U, La Fata V, Plutzky J, and Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135, 1998.
33. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, and Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95: 588-593, 1997.
34. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, and Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288, 2001.
35. Lee MY and Griendling KK. Redox signaling, vascular function, and hypertension. Antioxid Redox Signal 10: 1045-1059, 2008.
36. Li H, Horke S, and Forstermann U. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis 237: 208-219, 2014.
37. Libby P, Ridker PM, and Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 473: 317-325, 2011.
38. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, and Genest J, Jr. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354: 1567-1577, 2006.
39. Maier W, Cosentino F, Lutolf RB, Fleisch M, Seiler C, Hess OM, Meier B, and Luscher TF. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol 35: 173-178, 2000.
40. Napoli C, De Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, and Ignarro LJ. Nitric oxide and atherosclerosis: an update. Nitric Oxide 15: 265-279, 2006.
41. Ohashi Y, Kawashima S, Hirata K, Yamashita T, Ishida T, Inoue N, Sakoda T, Kurihara H, Yazaki Y, and Yokoyama M. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest 102: 2061-2071, 1998.
42. Oppermann M, Suvorava T, Freudenberger T, Dao VT, Fischer JW, Weber M, and Kojda G. Regulation of vascular guanylyl cyclase by endothelial nitric oxide-dependent posttranslational modification. Basic Res Cardiol 106: 539-549, 2011.
43. Ponnuswamy P, Schrottle A, Ostermeier E, Gruner S, Huang PL, Ertl G, Hoffmann U, Nieswandt B, and Kuhlencordt PJ. eNOS protects from atherosclerosis despite relevant superoxide production by the enzyme in apoE mice. PLoS One 7: e30193, 2012.
44. Radermacher KA, Wingler K, Langhauser F, Altenhofer S, Kleikers P, Hermans JJ, Hrabe de AM, Kleinschnitz C, and Schmidt HH. Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress. Antioxid Redox Signal 18: 1418-1427, 2013.
45. Raman CS, Li H, Martasek P, Kral V, Masters BS, and Poulos TL. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 95: 939-950, 1998.
46. Ravi K, Brennan LA, Levic S, Ross PA, and Black SM. S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc Natl Acad Sci U S A 101: 2619-2624, 2004.
47. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126, 1999.
48. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, and Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101: 731-736, 1998.
49. Satoh K, Nigro P, and Berk BC. Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A. Antioxid Redox Signal 12: 675-682, 2010.
50. Schmidt K, Andrew P, Schrammel A, Groschner K, Schmitz V, Kojda G, and Mayer B. Comparison of neuronal and endothelial isoforms of nitric oxide synthase in stably transfected HEK 293 cells. Am J Physiol Heart Circ Physiol 281: H2053-H2061, 2001.
51. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, and Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 300: 2123-2133, 2008.
52. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, and Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 93: 13176-13181, 1996.
53. Sugamura K and Keaney JF, Jr. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 51: 978-992, 2011.
54. Suvorava T, Lauer N, and Kojda G. Physical inactivity causes endothelial dysfunction in healthy young mice. JAm Coll Cardiol 44: 1320-1327, 2004.
55. Suvorava T, Lauer N, Kumpf S, Jacob R, Meyer W, and Kojda G. Endogenous vascular hydrogen peroxide regulates arteriolar tension in vivo. Circulation 112: 2487-2495, 2005.
56. Suvorava T, Stegbauer J, Thieme M, Pick S, Friedrich S, Rump LC, Hohlfeld T, and Kojda G. Sustained hypertension despite endothelial-specific eNOS rescue in eNOS-deficient mice. Biochem Biophys Res Commun 458: 576-583, 2015.
57. Tabima DM, Frizzell S, and Gladwin MT. Reactive oxygen and nitrogen species in pulmonary hypertension. Free Radic Biol Med 52: 1970-1986, 2012.
58. Vásquez-Vivar J, Kalyanaraman B, Martásek P, Hogg N, Masters BSS, Karoui H, Tordo P, and Pritchard KA, Jr. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci U S A 95: 9220-9225, 1998.
59. Xia Y, Tsai AL, Berka V, and Zweier JL. Superoxide generation from endothelial nitric-oxide synthase - a Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 273: 25804-25808, 1998.
60. Yogo K, Shimokawa H, Funakoshi H, Kandabashi T, Miyata K, Okamoto S, Egashira K, Huang P, Akaike T, and Takeshita A. Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice. Arterioscler Thromb Vasc Biol 20: E96-E100, 2000.
61. Yusuf S, Dagenais G, Pogue J, Bosch J, and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 154-160, 2000.
62. Zou MH, Shi C, and Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817-826, 2002.